1. S. M. Kupchan, M. Maruyama, R. J. Hemingway, et al., J. Am. Chem. Soc., 93(19), 4914–4916 (1971).
2. K. Zh. Musulmanbekov, Proceedings of the Int. Sci.-Pract. Conf. “Clinical Use of the Antitumor Drug Arglabin” [in Russian], Karaganda (2002), pp. 46–51.
3. K. D. Rakhimov, Pharmacological Characterization of Natural Substances of Kazakhstan [in Russian], Almaty (1999), pp. 43–64.
4. T. E. Shaikenov, Proceedings of the Int. Sci.-Pract. Conf. “Clinical Use of the Antitumor Drug Arglabin” [in Russian], Karaganda (2002), pp. 57–67.
5. I. V. Anikin, G. V. Kukushkina, I. S. Sokolova, et al., Izv. Akad. Nauk SSSR, Ser. Biol., No. 2, 291–295 (1981).